Abstract
Somatic RET mutations have been identified in a variable proportion (about 30 – 70%) of sporadic Medullary Thyroid Carcinoma (MTC) cases. They are represented by the Met918Thr substitution (exon 16) typical of Multiple Endocrine Neoplasia type 2B (MEN2B) and, to a lesser extent, by nucleotide changes occurring at one of five critical cysteine residues (exons 10 and 11) typical of MEN type 2A (MEN2A). An in vitro transforming activity has already been demonstrated for these mutations. A few different MTC somatic mutations have been reported so far whose biological activity has still to be tested. In this paper we report the identification, in two MTC tumor samples, of two interstitial deletions of 48 bp and 6 bp occurred in exons 10 and 11 respectively. Both were somatic heterozygous in frame mutations, not involving any cysteine residue. Moreover, the expression of a full length RET cDNA carrying one of the two deletions demonstrated a strong transforming capacity in NIH3T3 cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ceccherini, I., Pasini, B., Pacini, F. et al. Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene. Oncogene 14, 2609–2612 (1997). https://doi.org/10.1038/sj.onc.1201079
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201079
Keywords
This article is cited by
-
Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer
Journal of Experimental & Clinical Cancer Research (2020)
-
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
Nature Reviews Endocrinology (2016)
-
Diagnosi genetica del carcinoma midollare della tiroide: implicazioni diagnostiche e terapeutiche
L'Endocrinologo (2004)
-
Does a somatic deletion in RET clarify the sporadic nature of medullary thyroid carcinoma?
Journal of Endocrinological Investigation (2003)
-
The finding of a somatic deletion in RET exon 15 clarified the sporadic nature of a medullary thyroid carcinoma suspected to be familial
Journal of Endocrinological Investigation (2002)